Michael V. Knopp mostly deals with Magnetic resonance imaging, Nuclear medicine, Radiology, Pathology and Dynamic contrast-enhanced MRI. His Magnetic resonance imaging study combines topics in areas such as Lesion, Medical imaging, Lymph, Medical physics and Stenosis. His research integrates issues of Blood flow, Mr imaging, Central nervous system disease, Contrast and Glioma in his study of Nuclear medicine.
His study in Radiology is interdisciplinary in nature, drawing from both Renal artery, Renal artery stenosis and Intraindividual comparison. His Pathology research includes elements of Metastasis, Vascular endothelial growth factor and Dynamic contrast. His Dynamic contrast-enhanced MRI research is multidisciplinary, incorporating perspectives in Angiogenesis, Neuroradiology, Ultrasound, Contrast medium and Arterial blood.
Michael V. Knopp focuses on Nuclear medicine, Radiology, Magnetic resonance imaging, Pathology and Internal medicine. His research in Nuclear medicine intersects with topics in Image quality, Lesion, Mr imaging and Contrast. His Image quality research incorporates themes from Photon counting, Imaging phantom and Voxel.
Michael V. Knopp interconnects Cancer and Neuroradiology in the investigation of issues within Radiology. The Magnetic resonance imaging study combines topics in areas such as Radiation therapy and Nuclear magnetic resonance. Michael V. Knopp studies Carcinoma, a branch of Pathology.
His main research concerns Nuclear medicine, Radiology, PET-CT, Image quality and Medical physics. His Nuclear medicine study incorporates themes from Lesion, Pet ct imaging and Biodistribution. The various areas that he examines in his Radiology study include Bladder cancer and Cancer.
His Image quality study integrates concerns from other disciplines, such as Photon counting, Imaging phantom, Voxel and Iterative reconstruction. His Medical physics research integrates issues from Clinical trial, Radiation therapy and Medical imaging. Many of his studies on Magnetic resonance imaging apply to Osteoarthritis as well.
His scientific interests lie mostly in Nuclear medicine, Radiology, Positron emission tomography, Magnetic resonance imaging and Internal medicine. His work deals with themes such as Lesion, Brachytherapy and Sagittal plane, which intersect with Nuclear medicine. Michael V. Knopp combines subjects such as Cancer and Tolerability with his study of Radiology.
His Positron emission tomography study combines topics from a wide range of disciplines, such as Photon counting, Detector and Molecular imaging. His work on Mri techniques as part of general Magnetic resonance imaging research is frequently linked to Water holding, bridging the gap between disciplines. His Internal medicine course of study focuses on Oncology and Clinical trial, Medical physicist, Potential biomarkers, Radiomics and Interventional treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Paul S. Tofts;Gunnar Brix;David L. Buckley;Jeffrey L. Evelhoch.
Journal of Magnetic Resonance Imaging (1999)
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Richard T. Kloos;Matthew D. Ringel;Michael V. Knopp;Nathan C. Hall.
Journal of Clinical Oncology (2009)
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
Martin O Leach;K Brindle;J Evelhoch;John R Griffiths.
British Journal of Cancer (2005)
Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Peter L. Choyke;Andrew J. Dwyer;Michael V. Knopp.
Journal of Magnetic Resonance Imaging (2003)
Pathophysiologic basis of contrast enhancement in breast tumors.
M.V. Knopp;E. Weiss;H.P. Sinn;J. Mattern.
Journal of Magnetic Resonance Imaging (1999)
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Elaine T. Lam;Matthew D. Ringel;Richard T. Kloos;Thomas W. Prior.
Journal of Clinical Oncology (2010)
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
Benjamin M. Ellingson;Martin Bendszus;Martin Bendszus;Jerrold Boxerman;Daniel Barboriak.
Neuro-oncology (2015)
Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography
U Hoffmann;G Brix;M V Knopp;T Hess.
Magnetic Resonance in Medicine (1995)
Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging.
H U Kauczor;D Hofmann;K F Kreitner;H Nilgens.
Radiology (1996)
MR imaging of tumor microcirculation: Promise for the new millenium
June S. Taylor;June S. Taylor;Paul S. Tofts;Ruediger Port;Jeffrey L. Evelhoch.
Journal of Magnetic Resonance Imaging (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Manitoba
University Hospital Heidelberg
Heidelberg University
National Institutes of Health
Goethe University Frankfurt
Heidelberg University
West Virginia University
Icahn School of Medicine at Mount Sinai
Memorial Sloan Kettering Cancer Center
Heidelberg University
Zhejiang University
Actifio
Polish Academy of Sciences
Tsinghua University
Kanazawa Institute of Technology
Spanish National Research Council
University of Udine
University of Toronto
Aarhus University
Instituto de Ecología
University of Córdoba
Otto-von-Guericke University Magdeburg
Leiden University Medical Center
University of Mississippi
University of Pennsylvania
University of Cagliari